AI Tokens
Stock Analysis on Net

Zoetis Inc. (NYSE:ZTS)

This company has been moved to the archive! The financial data has not been updated since May 2, 2024.

Income Statement
Quarterly Data

Zoetis Inc., consolidated income statement (quarterly data)

US$ in millions

Microsoft Excel
3 months ended: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021 Dec 31, 2020 Sep 30, 2020 Jun 30, 2020 Mar 31, 2020 Dec 31, 2019 Sep 30, 2019 Jun 30, 2019 Mar 31, 2019
Revenue 2,190 2,213 2,151 2,180 2,000 2,040 2,002 2,052 1,986 1,967 1,990 1,948 1,871 1,807 1,786 1,548 1,534 1,674 1,584 1,547 1,455
Cost of sales (643) (728) (638) (607) (588) (653) (607) (625) (569) (600) (586) (568) (549) (601) (546) (451) (459) (530) (479) (465) (518)
Gross profit 1,547 1,485 1,513 1,573 1,412 1,387 1,395 1,427 1,417 1,367 1,404 1,380 1,322 1,206 1,240 1,097 1,075 1,144 1,105 1,082 937
Selling, general and administrative expenses (547) (565) (525) (556) (505) (514) (501) (529) (465) (593) (504) (495) (409) (520) (424) (393) (389) (472) (391) (406) (369)
Research and development expenses (162) (174) (152) (146) (142) (148) (134) (135) (122) (138) (132) (120) (118) (133) (112) (111) (107) (132) (112) (111) (102)
Amortization of intangible assets (37) (37) (38) (37) (37) (35) (37) (37) (41) (40) (40) (41) (40) (40) (40) (40) (40) (40) (38) (39) (38)
Restructuring charges and certain acquisition-related costs (4) (8) (16) (8) (21) (2) (6) (1) (2) (4) (9) (21) (9) (3) (5) (8) (9) (18) (6) (22) (5)
Operating income 797 701 782 826 707 688 717 725 787 592 719 703 746 510 659 545 530 482 558 504 423
Interest expense, net of capitalized interest (58) (59) (59) (58) (63) (62) (53) (53) (53) (54) (56) (57) (57) (58) (62) (58) (53) (56) (56) (55) (56)
Other income (deductions), net 8 8 (6) 104 53 (34) 3 (2) (7) (32) (4) (10) (2) (32) — (5) 20 11 26 6 14
Income before provision for taxes on income 747 650 717 872 697 592 667 670 727 506 659 636 687 420 597 482 497 437 528 455 381
Provision for taxes on income (148) (127) (121) (202) (146) (132) (139) (141) (133) (93) (107) (125) (129) (62) (118) (106) (74) (53) (95) (84) (69)
Net income before allocation to noncontrolling interests 599 523 596 670 551 460 528 529 594 413 552 511 558 358 479 376 423 384 433 371 312
Net loss attributable to noncontrolling interests — 2 — 1 1 1 1 — 1 1 — 1 1 1 — 1 — — — — —
Net income attributable to Zoetis Inc. 599 525 596 671 552 461 529 529 595 414 552 512 559 359 479 377 423 384 433 371 312

Based on: 10-Q (reporting date: 2024-03-31), 10-K (reporting date: 2023-12-31), 10-Q (reporting date: 2023-09-30), 10-Q (reporting date: 2023-06-30), 10-Q (reporting date: 2023-03-31), 10-K (reporting date: 2022-12-31), 10-Q (reporting date: 2022-09-30), 10-Q (reporting date: 2022-06-30), 10-Q (reporting date: 2022-03-31), 10-K (reporting date: 2021-12-31), 10-Q (reporting date: 2021-09-30), 10-Q (reporting date: 2021-06-30), 10-Q (reporting date: 2021-03-31), 10-K (reporting date: 2020-12-31), 10-Q (reporting date: 2020-09-30), 10-Q (reporting date: 2020-06-30), 10-Q (reporting date: 2020-03-31), 10-K (reporting date: 2019-12-31), 10-Q (reporting date: 2019-09-30), 10-Q (reporting date: 2019-06-30), 10-Q (reporting date: 2019-03-31).


Financial performance across the analyzed period demonstrates a consistent upward trajectory in both top-line revenue and bottom-line profitability. There is a clear trend of scaling operations accompanied by an expansion in profit margins, indicating strong operational leverage and pricing stability.

Revenue and Gross Profitability
Quarterly revenue increased from 1,455 million USD in March 2019 to 2,190 million USD by March 2024. Gross profit followed a similar growth pattern, rising from 937 million USD to 1,547 million USD. The gross margin has expanded over time, moving from approximately 64.4% in the first quarter of 2019 to 70.6% by the first quarter of 2024, suggesting improved cost efficiencies in the cost of sales.
Operational Efficiency
Operating income grew significantly from 423 million USD to 797 million USD. The operating margin improved from roughly 29.1% to 36.4% over the five-year span. This indicates that revenue growth has outpaced the growth of operating expenses, allowing a larger portion of each dollar of revenue to reach the operating profit line.
Expense Analysis
Research and development expenditures showed a steady and disciplined increase, rising from 102 million USD to 162 million USD, reflecting a consistent investment in the product pipeline. Selling, general, and administrative expenses also increased from 369 million USD to 547 million USD, though these costs fluctuated more significantly across quarters compared to R&D spending.
Net Income and Bottom-Line Performance
Net income attributable to the company increased from 312 million USD in March 2019 to 599 million USD in March 2024. Despite this long-term growth, quarterly net income experienced volatility, particularly in 2021 and 2023. These fluctuations are primarily attributable to variations in the provision for income taxes and non-operating items, such as "Other income (deductions), net," which saw a notable peak of 104 million USD in June 2023.

AI Ask an analyst for more

Hi, I’m an AI-powered financial analyst at Stock Analysis on Net.
Without a user account, I tend to respond rather slowly.

How can I help you?